Académique Documents
Professionnel Documents
Culture Documents
SOLUTION DU CANCER
PAR
LA MEDECINE ALTERNATIVE
Alexis HARIMENSHI
Ph.D candidate on multi-drug resistant cells of human cancer
Specialization: Immunology, Molecular Medicine and Applied Biotechnology
Spécialité : Immunologie, Médecine Moléculaire et Biotechnologie Appliquée
Contact:
WhatsApp: (+257) 79 666 439
Email: harimenshi2022@gmail.com
ii
Introduction
Chapitre I :
CANCER, SA NATURE ET SON DÉVELOPPEMENT
I.1. Cancer c’est quoi ?
1
Jean Rosa, Généralités sur la cancérogenèse Generalities about
carcinogenesis, Comptes Rendus Biologies, Volume 331, Issue 2, February
2008, Pages 114-125, adapté le 06/12/2023 :
https://www.sciencedirect.com/science/article/pii/S1631069107001187#:~:text=
Certains%20agents%20cancérogènes%2C%20tels%20le,initiation%20de%20cel
ui%20de%20promotion.
2
Institut National de la Recherche Scientifique (INRS), CANCERS
PROFESSIONNELS (07/1/2015), adapté le 06/12/2023 :
https://www.inrs.fr/risques/cancers-professionnels/agents-cancerogenes-
reconnus.html
5
3
Catarina V. Jota Baptista, ... Paula A. Oliveira, Carcinogenesis, Reference
Module in Biomedical Sciences, 2023, adaptee le 06/12/2023:
https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-
biology/carcinogenesis#:~:text=Carcinogenesis%20may%20initiate%20by%20t
he,not%20repair%20the%20DNA%20damage.
4
Andrew D. Miller, Neoplasia and Proliferative Disorders of Nonhuman
Primates, Nonhuman Primates in Biomedical Research (Second Edition),
Volume 2, 2012, adapté le 06/12/2023 : https://www.inrs.fr/risques/cancers-
professionnels/agents-cancerogenes-reconnus.html
6
5
WHO, International Agency for Research on Cancer (IARC)‘s September 12,
2018 latest global cancer data, Press release No 263, pp.1-2
6
Africa‘s Emerging Cancer Crisis: A Call to Action, June 2017: Available at:
https://bvgh.org/wp-content/uploads/2017/07/Africas-Emerging-Cancer-Crisis-
A-Call-to-Action.pdf, accessed (16th June 2020)
7
7
The World Health Organization (WHO), 12 September 2018
8
American Cancer Society, the global economic cost of cancer (2010), page 2,
Available at: file:///C:/Users/user/AppData/Local/Temp/08-17-
2010_economic_impact_study.pdf, Accessed (November 8, 2020).
8
9
National Geographic, October 23, 2013, ADAPTED ON jULY 20,
2023:https://www.nationalgeographic.com/science/article/how-many-cells-are-
in-your-
body#:~:text=37.2%20trillion%20cells.,magnitude%20except%20in%20the%20
movies.
9
RAD9
PARP1
BRCA1
ATM
I.3.1. Initiation
I.3.2. Promotion
Chapitre II :
16
US National Cancer Institute, benzo(a)pyrene (Date not indicated), adapted on
July 26, 2023: https://www.cancer.gov/publications/dictionaries/cancer-
terms/def/benzoapyrene.
17
International Agency for Research on Cancer, BENZO[a]PYRENE (2012),
adapted on July 26, 2023:https://www.ncbi.nlm.nih.gov/books/NBK304415/
18
Emilien L. Jamin, Anne Riu, Thierry Douki, Laurent Debrauwer, Jean-Pierre
Cravedi, Daniel Zalko1, Marc Audebert, Combined Genotoxic Effects of a
Polycyclic Aromatic Hydrocarbon (B(a)P) and an Heterocyclic Amine (PhIP) in
Relation to Colorectal Carcinogenesis (March 6, 2013), adapted on July 26,
2023:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590161/pdf/pone.0058591.pdf
19
19
Deliang Tang, Jason J. Liu, Andrew Rundle, Christine Neslund-Dudas, Adnan
T. Savera, Cathryn H. Bock, Nora L. Nock, James J. Yang, and Benjamin A.
Rybicki, Grilled Meat Consumption and PhIP-DNA Adducts in Prostate
Carcinogenesis (December 12, 2012), adapted on July 26, 2023:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2132437/pdf/nihms34464.pdf
20
National Library of Medicine, BENZO[a]PYRENE (2012), adapted on July
26, 2023:https://www.ncbi.nlm.nih.gov/books/NBK304415/
21
Nelson DE, Jarman DW, Rehm J, et al. Alcohol-attributable cancer deaths and
years of potential life lost in the United States. American Journal of Public
Health 2013; 103(4):641–648. [PubMed Abstract]
22
IARC Working Group on the Evaluation of Carcinogenic Risks to
Humans. Alcohol consumption and ethyl carbamateExit Disclaimer. IARC
Monographs on the Evaluation of Carcinogenic Risks in Humans 2010; 96:3–
1383.
20
28
Stadler,R.H. et al. (2002) Acrylamide from Maillard reaction products.
Nature, 419, 449–450.
29
Mottram,D.S. et al. (2002) Acrylamide is formed in the Maillard reaction.
Nature, 419, 448–449.
30
National Cancer Institute, Acrylamide and Cancer Risk (December 5, 2017),
adapted on July 27, 2023: https://www.cancer.gov/about-cancer/causes-
prevention/risk/diet/acrylamide-fact-
sheet#:~:text=Studies%20in%20rodent%20models%20have,in%20and%20dam
age%20to%20DNA.
23
31
Francesco Esposito, Jonathan Squillante, Agata Nolasco, Paolo Montuori, Pasq
uale Giuseppe Macrì, Teresa Cirillo, Acrylamide levels in smoke from
conventional cigarettes and heated tobacco products and exposure assessment
in habitual smokers (3 January 2022), adapted on July 27, 2023:
https://www.sciencedirect.com/science/article/abs/pii/S0013935121019605
24
32
Fu, D., Calvo, J. A., & Samson, L. D. (2012). Balancing repair and tolerance
of DNA damage caused by alkylating agents. Nature Reviews Cancer, 12, 104-
120. http://doi.org/10.1038/nrc3185 (Original work published feb)
33
Rheingold, S. R., Neugut, A. I., & Meadows, A. T. (2003). Therapy-Related
Secondary Cancers. Holland-Frei Cancer Medicine. 6Th Edition. Consulté à
l'adresse https://www.ncbi.nlm.nih.gov/books/NBK13999/
25
34
Kate Li,Karin Ricker,Feng C. Tsai,ChingYi J. Hsieh,Gwendolyn
Osborne,nMeng Sun,M. Elizabeth Marder,Sarah Elmore,Rose
Schmitz,and Martha S. Sandy,Estimated Cancer Risks Associated with
Nitrosamine Contamination in Commonly Used Medications (September 8,
2021), adapted on July 27, 2023:https://www.mdpi.com/1660-4601/18/18/9465
35
H. Robles, Nitrosamines,Encyclopedia of Toxicology, Third Edition (2014),
adapted on July 28, 2023: https://www.sciencedirect.com/topics/chemical-
engineering/nitrosamines#:~:text=It%20is%20known%20that%20carcinogenic,t
he%20formation%20of%20carcinogenic%20nitrosamines.
36
Larsson S.C., Orsini N., Wolk A. Processed meat consumption and stomach
cancer risk: A meta-analysis. J. Natl. Cancer Inst. 2006;98:1078–1087.
26
39
Tricker A.R., Preussmann R. Carcinogenic N-nitrosamines in the diet:
Occurrence, formation, mechanisms and carcinogenic potential. Mutat.
Res. 1991;259:277–289.doi: 10.1016/0165-1218(91)90123-4. [PubMed]
[CrossRef] [Google Scholar] [Ref list]
40
Anderson L.M., Souliotis V.L., Chhabra S.K., Moskal T.J., Harbaugh S.D.,
Kyrtopoulos S.A. N-nitrosodimethylamine-derived O(6)-methylguanine in DNA
of monkey gastrointestinal and urogenital organs and enhancement by
ethanol. Int. J. Cancer. 1996;66:130–134. doi: 10.1002/(SICI)1097-
0215(19960328)66:1<130::AID-IJC22>3.0.CO;2-G. [PubMed]
[CrossRef] [Google Scholar] [Ref list]
28
41
US Centers for Disease Control and Prevention, The Electromagnetic
Spectrum: Ionizing Radiation, The Electromagnetic Spectrum: Ionizing
Radiation (June 29, 2021), adapted on July 31,
2023:https://www.cdc.gov/nceh/radiation/ionizing_radiation.html#:~:text=Non-
ionizing%20radiation%20is%20a,%2C%20water%2C%20and%20living%20tiss
ue.
42
Megan Wessel, Tracy Wyant, Christopher Peña, Maria Cabrera, Rick Alteri,
Qin Zhang, Barbara Lubejko, Danielle Robertson, Kirsten Eidsmoe, Christina
Thomas, Beverly Greene, Rafael Delfin-Davis, Radiofrequency (RF) Radiation,
American, Cancer Society cancer.org | 1.800.227.2345 (Date note indicated),
ada[ted on July 31, 2023:
https://www.cancer.org/content/dam/CRC/PDF/Public/8060.00.pdf
30
43
S.A. Savage, J. Schüz, Environmental Chemicals and Childhood Cancer,
Encyclopedia of Environmental Health (2011), adapted on July 31, 2023:
https://www.sciencedirect.com/topics/earth-and-planetary-sciences/ionizing-
raypnnement
44
Shahidi M., Mozdarani H., Mueller W.U. Radiosensitivity and repair kinetics
of gamma-irradiated leukocytes from sporadic prostate cancer patients and
healthy individuals assessed by alkaline comet assay. Iran. Biomed.
J. 2010;14:67–75. [PMC free article] [PubMed] [Google Scholar] [Ref list]
45
Cybulski C., Huzarski T., Górski B., Masojć B., Mierzejewski M., Debniak T.,
Gliniewicz B., Matyjasik J., Złowocka E., Kurzawski G., et al. A novel founder
CHEK2 mutation is associated with increased prostate cancer risk. Cancer
Res. 2004;64:2677–2679. [PubMed] [Google Scholar] [Ref list]
46
Angèle S., Jones C., Reis Filho J.S., Fulford L.G., Treilleux I., Lakhani S.R.,
Hall J. Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in
myoepithelial cells from benign and malignant proliferations of the breast. J.
Clin. Pathol. 2004;57:1179–1184. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
47
Edwards S.M., Kote-Jarai Z., Meitz J., Hamoudi R., Hope Q., Osin P., Jackson
R., Southgate C., Singh R., Falconer A., Dearnaley D.P., et al. Two percent of
men with early-onset prostate cancer harbor germline mutations in the BRCA2
gene. Am. J. Hum. Genet. 2003;72:1–12. doi: 10.1086/345310. [PMC free
article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
31
48
Hossein Mozdarani, Biological Complexities in Raypnnement Carcinogenesis
and Cancer Radiotherapy: Impact of New Biological Paradigms (January 20,
2012), ADAPTED ON July 31, 2023:https://www.mdpi.com/2073-4425/3/1/90
49
Gissela Borrego-Soto, Rocío Ortiz-López and Augusto Rojas-Martínez,
Ionizing radiation-induced DNA injury and damage detection in patients with
breast cancer (July 15, 2015). Adapted on July 31, 2023:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763322/pdf/1415-4757-gmb-
S1415-475738420150019.pdf
50
Masuda Y and Kamiya K (2012) Molecular nature of radiation injury and
DNA repair disorders associated with radiosensitivity. Int J Lab Hematol
95:239-245
51
Delaney G, Jacob S, Featherstone C and Barton M (2005) The role of
radiotherapy in cancer treatment estimating optimal utilization from a review of
evidence-based clinical guidelines. Cancer 104:1129-1137.
52
Redon CE, Nakamura AJ, Zhang Y-W, Ji JJ, Bonner WM, Kinders RJ,
Parchment RE, Doroshow JH and Pommier Y Borrego-Soto et al. 431 (2010)
Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic
biomarkers. Clin Cancer Res 16:4532-4542
32
57
Zanetti R, Rosso S, Martinez C, et al. The multicenter south European study «
Helios ». I. Skin characteristics and sunburns in basal and squamous cell
carcinomas of the skin. Br J Cancer 1996 ; 73 : 1440-6.
58
Magnaldo T. La « guerre » du NER (nucleotide excision repair). Med Sci
(Paris) 2004 ; 20 : 268-70.
59
Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to
the development of skin cancer. Mutat Res 2005 ; 571 : 91-106
60
Carolyn M. Hutter, Ph.D., Carcinogen, National Human Genome Research
Institute (August 1, 2023), ADAPTED ON August 2, 2023:
https://www.genome.gov/genetics-
glossary/Carcinogen#:~:text=Definition,exhaust%20fumes%20and%20cigarette
%20smoke).
34
61
S. Khan, A. Imran, A. A. Khan, M. Abul Kalam, and A. Alshamsan, ―Systems
biology approaches for the prediction of possible role of Chlamydia pneumoniae
proteins in the etiology of lung cancer,‖ PLoS One, vol. 11, no. 2, article
e0148530, 2016.
62
Institut Pasteur, Les cancers d’origine infectieuse (Le 06/7/2017), adapté le
03/8/2023 : https://www.pasteur.fr/fr/journal-recherche/dossiers/cancers-origine-
infectieusehttps://www.pasteur.fr/fr/journal-recherche/dossiers/cancers-origine-
infectieuse
63
zur Hausen H & de Villiers EM Cancer ―causation‖ by infections — individual
contributions and synergistic networks. Semin. Oncol 41, 860–875 (2014).
[PubMed] [Google Scholar] [Ref list]
64
Kazim Yalcin Arga, Medi Kori, Current status of viral biomarkers for
oncogenic viruses(2023), adapted on August 1, 2023:
https://www.sciencedirect.com/topics/immunology-and-
microbiology/oncovirus#:~:text=Oncovirus%20infections%20are%20widesprea
d%20and,DNA%2C%20RNA%2C%20and%20retroviruses.
35
67
Vangipuram R, Tyring SK (2019) AIDS-associated malignancies. Cancer
Treat Res 177:1–21 [PubMed] [Google Scholar] [Ref list]
37
68
Vangipuram R, Tyring SK (2019) AIDS-associated malignancies. Cancer
Treat Res 177:1–21 [PubMed] [Google Scholar] [Ref list]
69
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S
(2016) Global burden of cancers attributable to infections in 2012: a synthetic
analysis. Lancet Glob Health 4(9):e609–e616 [PubMed] [Google Scholar] [Ref
list]
70
de Martel C, Plummer M, Vignat J, Franceschi S (2017) Worldwide burden of
cancer attributable to HPV by site, country and HPV type. Int J
Cancer 141(4):664–670 [PMC free article] [PubMed] [Google Scholar] [Ref
list]
71
Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P,
Kisseljov F, Durst M, Schneider A, von Knebel Doeberitz M (2008) Type-
dependent integration frequency of human papillomavirus genomes in cervical
lesions. Cancer Res 68(1):307–313 [PubMed] [Google Scholar] [Ref list]
72
Biological agents volume 100 B, A review of human carcinogens, Lion,
38
74
Iyshwarya Bhaskar Kalarani, Ramakrishnan Veerabathiran, Oncoviruses:
future prospects of molecular mechanisms and therapeutic strategies(2023),
adapted on August 1, 2023: https://www.sciencedirect.com/topics/immunology-
and-
microbiology/oncovirus#:~:text=Oncovirus%20infections%20are%20widesprea
d%20and,DNA%2C%20RNA%2C%20and%20retroviruses.
75
Vaishak Kaviarasan, Ramakrishnan Veerabathiran, Bioinformatics serving
oncoviral studies (2023), adapted on August 1, 2023:
https://www.sciencedirect.com/topics/immunology-and
microbiology/oncovirus#:~:text=Oncovirus%20infections%20are%20widesprea
d%20and,DNA%2C%20RNA%2C%20and%20retroviruses.
76
Yeo-Teh N.S.L., Ito Y., Jha S. High-Risk Human Papillomaviral Oncogenes
E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis. Int. J. Mol.
Sci. 2018;19:1706. doi: 10.3390/ijms19061706. [PMC free article] [PubMed]
[CrossRef] [Google Scholar] [Ref list]
77
Longworth M.S., Laimins L.A. Pathogenesis of Human Papillomaviruses in
Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 2004;68:362–372.
doi: 10.1128/MMBR.68.2.362-372.2004. [PMC free article] [PubMed]
[CrossRef] [Google Scholar] [Ref list]
40
90
Kraft, M., S. Riedel, C. Maaser, T. Kucharzik, A. Steinbuechel, W. Domschke,
and N. Luegering. 2001. IFN-gamma synergizes with TNF-alpha but not with
viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial
cells. Clin. Exp. Immunol. 126:474-481. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
91
Cheng, K. C., D. S. Cahill, H. Kasai, S. Nishimura, and L. A. Loeb. 1992. 8-
Hydroxyguanine, an abundant form of oxidative DNA damage, causes G—-T
and A—-C substitutions. J. Biol. Chem. 267:166-172. [PubMed] [Google
Scholar] [Ref list]
92
Meyer-ter-Vehn, T., A. Covacci, M. Kist, and H. L. Pahl. 2000. Helicobacter
pylori activates mitogen-activated protein kinase cascades and induces
expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275:16064-
16072. [PubMed] [Google Scholar] [Ref list]
93
Mager DL. Bacteria and cancer: Cause, coincidence or cure? A review. J
Transl Med. 2006;4:14. doi: 10.1186/1479-5876-4-14. [PubMed: 16566840].
44
95
Coussens, L. M., and Z. Werb. 2002. Inflammation and
cancer. Nature 420:860-867. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
46
101
Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, et al.
High-protein, reduced-carbohydrate weight-loss diets promote metabolite
profiles likely to be detrimental to colonic health. Am J Clin Nutr.
2011;93(5):1062–72. doi: 10.3945/ajcn.110.002188. [PubMed: 21389180].
102
Smith, J. T., R. E. Pounder, C. U. Nwokolo, S. Lanzon-Miller, D. G. Evans,
D. Y. Graham, and D. J. Evans, Jr. 1990. Inappropriate hypergastrinaemia in
asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522-
525. [PMC free article] [PubMed] [Google Scholar] [Ref list]
48
103
Dickson, J. H., A. Grabowska, M. El-Zaatari, J. Atherton, and S. A.
Watson. 2006. Helicobacter pylori can induce heparin-binding epidermal growth
factor expression via gastrin and its receptor. Cancer Res. 66:7524-7531.
[PubMed] [Google Scholar] [Ref list]
104
Varro, A., P. J. Noble, L. E. Wroblewski, L. Bishop, and G. J. Dockray. 2002.
Gastrin-cholecystokinin(B) receptor expression in AGS cells is associated with
direct inhibition and indirect stimulation of cell proliferation via paracrine
activation of the epidermal growth factor receptor. Gut 50:827-833. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
105
Takaishi, S., S. Tu, Z. A. Dubeykovskaya, M. T. Whary, S. Muthupalani, B.
H. Rickman, A. B. Rogers, N. Lertkowit, A. Varro, J. G. Fox, and T. C.
Wang. 2009. Gastrin is an essential cofactor for helicobacter-associated gastric
corpus carcinogenesis in C57BL/6 mice. Am. J. Pathol. 175:365-375. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
106
Wang, T. C., C. A. Dangler, D. Chen, J. R. Goldenring, T. Koh, R.
Raychowdhury, R. J. Coffey, S. Ito, A. Varro, G. J. Dockray, and J. G.
Fox. 2000. Synergistic interaction between hypergastrinemia and Helicobacter
infection in a mouse model of gastric cancer. Gastroenterology 118:36-47.
[PubMed] [Google Scholar] [Ref list]
49
107
Takhar, A. S., O. Eremin, and S. A. Watson. 2004. The role of gastrin in
colorectal carcinogenesis. Surgeon 2:251-257. [PubMed] [Google Scholar] [Ref
list]
108
Zhou, Q., H. Zhang, X. Pang, J. Yang, Z. Tain, Z. Wu, and Z. Yang. 1992.
Pre- and postoperative sequential study on the serum gastrin level in patients
with lung cancer. J. Surg. Oncol. 51:22-25. [PubMed] [Google Scholar] [Ref
list]
109
A. M. O‘Hara, A. Bhattacharyya, J. Bai et al., ―Tumor necrosis factor (TNF)-
α-induced IL-8 expression in gastric epithelial cells: Role of reactive oxygen
species and AP endonuclease1/redox factor (Ref )-1,‖ Cytokine, vol. 46, no. 3,
pp. 359–369, 2009.
50
110
A. M. O‘Hara, A. Bhattacharyya, J. Bai et al., ―Tumor necrosis factor (TNF)-
α-induced IL-8 expression in gastric epithelial cells: Role of reactive oxygen
species and AP endonuclease1/redox factor (Ref )-1,‖ Cytokine, vol. 46, no. 3,
pp. 359–369, 2009.
111
G. R. Davies, C. E. Collins, N. Banatvala et al., ―A direct relationship
between infective load of Helicobacter pylori and oxygen free radical production
in antral mucosal biopsies,‖ Gut, vol. 34, Supplement 1, pp. 73–79, 1993.
112
A. P. Gobert and K. T. Wilson, ―Polyamine- and NADPHdependent
generation of ROS during Helicobacter pylori infection: A blessing in disguise,‖
Free Radical Biology & Medicine, vol. 105, pp. 16–27, 2017
113
O. Handa, Y. Naito, and T. Yoshikawa, ―Redox biology and gastric
carcinogenesis: the role ofHelicobacter pylori,‖ Redox Report, vol. 16, no. 1, pp.
1–7, 2013.
114
S. Kyung, J. W. Lim, and H. Kim, ―α-Lipoic acid inhibits IL-8 expression by
activating Nrf 2 signaling in Helicobacter pylori-infected gastric epithelial
cells,‖ Nutrients, vol. 11, no. 10, p. 2524, 2019
115
D. Kidane, W. J. Chae, J. Czochor et al., ―Interplay between DNA repair and
inflammation, and the link to cancer,‖ Critical Reviews in Biochemistry and
Molecular Biology, vol. 49, no. 2, pp. 116–139, 2013.
51
119
Mager DL. Bacteria and cancer: Cause, coincidence or cure? A review. J
Transl Med. 2006;4:14. doi: 10.1186/1479-5876-4-14. [PubMed: 16566840].
[PubMed Central: PMC1479838].
120
Sears CL, GarrettWS. Microbes, microbiota, and colon cancer. Cell Host
Microbe. 2014;15(3):317–28. doi: 10.1016/j.chom.2014.02.007. [PubMed:
24629338]. [PubMed Central: PMC4003880].
53
121
Aayush Dhakal; Muhammad F. Hashmi; Evelyn Sbar.,Aflatoxin Toxicity,
National Center for Biotechnology Information (February 19, 2023.), adapted on
August 26,
2023:https://www.ncbi.nlm.nih.gov/books/NBK557781/#:~:text=Aflatoxin%20t
oxicity%20may%20result%20in,%2C%20cirrhosis%2C%20and%20hepatocellu
lar%20carcinoma.
122
D. Anderson, T.C. Marrs, in Encyclopedia of Food and Health (2016),
Organic Chemical Carcinogens in Other Edible Plants and in Microorganisms,
adapted on July 30, 2023:https://www.sciencedirect.com/topics/pharmacology-
toxicology-and-pharmaceutical-science/carcinogen.
123
Kamkar A, Yazdankhah S, Nafchi AM, Nejad AS. Aflatoxin M1 in raw cow
and buffalo milk in Shush city of Iran. Food Addit Contam Part B
Surveill. 2014;7(1):21-4. [PubMed] [Reference list]
124
Marchese S, Polo A, Ariano A, Velotto S, Costantini S, Severino L. Aflatoxin
B1 and M1: Biological Properties and Their Involvement in Cancer
Development. Toxins (Basel). 2018 May 24;10(6) [PMC free article]
[PubMed] [Reference list]
125
Kumar P, Mahato DK, Kamle M, Mohanta TK, Kang SG. Aflatoxins: A
Global Concern for Food Safety, Human Health and Their Management. Front
Microbiol. 2016;7:2170. [PMC free article] [PubMed] [Reference list]
54
126
Kew MC. Hepatocellular carcinoma in developing countries: Prevention,
diagnosis and treatment. World J Hepatol. 2012 Mar 27;4(3):99-104. [PMC free
article] [PubMed] [Reference list]
127
Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human
aflatoxicosis in developing countries: a review of toxicology, exposure, potential
health consequences, and interventions. Am J Clin Nutr. 2004 Nov;80(5):1106-
22. [PubMed] [Reference list]
128
Aguilar F, Hussain SP, Cerutti P. Aflatoxin B1 induces the transversion of G--
>T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc
Natl Acad Sci U S A. 1993 Sep 15;90(18):8586-90. [PMC free article]
[PubMed] [Reference list]
129
Jolly PE, Inusah S, Lu B, Ellis WO, Nyarko A, Phillips TD, Williams JH.
Association between high aflatoxin B1 levels and high viral load in HIV-positive
people. World Mycotoxin J. 2013;6(3):255-261. [PMC free article]
[PubMed] [Reference list]
55
130
Silvio De Flora and Paolo Bonanni, The prevention of infection-associated
cancers, Carcinogenesis vol.32 no.6 pp.787–795, 2011
doi:10.1093/carcin/bgr054 Advance Access publication March 24, 2011,
adapted on December 26, 2023: watermark.silverchair.com/bgr054.pdf
56
Chapitre III :
LE CANCER ET SA RESISTANCE POLY-
MEDICAMENTEUSE
CHAPITRE IV :
ALIMENTATION ET PREVENTION
CONTRE LE CANCER
144
Chaichian S., Moazzami B., Sadoughi F., Kashani H.H., Zaroudi M., Asemi
Z. Functional activities of beta-glucans in the prevention or treatment of cervical
cancer. Journal of Ovarian Research. 2020;13(1):1–12. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
145
Park J.-E., Gallagher T. Lipidation increases antiviral activities of coronavirus
fusion-inhibiting peptides. Virology. 2017;511:9–18. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
146
Reboul E. Vitamin E bioavailability: Mechanisms of intestinal absorption in
the spotlight. Antioxidants. 2017;6(4):95. doi: 10.3390/antiox6040095. [PMC
free article] [PubMed] [CrossRef] [Google Scholar] [Ref list] Brown G.D.,
Gordon S. Immune recognition of fungal β‐glucans. Cellular
Microbiology. 2005;7(4):471–479. [PubMed] [Google Scholar] [Ref list]
66
157
Franck A, De Leenheer L. Inulin. Biopolymers Online. iley-VCH Verlag
GmbH & Co. KGaA, Weinheim; 2005
158
Jain AK, Sood V, Bora M, Vasita R, Katti DS. Electrosprayed inulin
microparticles for microbiota triggered targeting of colon. Carbohydr Polym.
2014;112:225-234. doi: 10.1016/j. carbpol.2014.05.087.
159
Sahiner N, Sagbas S. Multifunctional tunable p (inulin) microgels. Mater
Sci Eng C. 2014;40:366-372. doi: 10.1016/j.msec.2014.04.028
160
Taper HS, Roberfroid MB. Possible adjuvant cancer therapy by two
prebiotics-inulin or oligofructose. In vivo. 2005;19(1):201-204
161
Marisol Rivera-Huerta, Vania Lorena Lizárraga-Grimes, Ibrahim Guillermo
Castro-Torres, Mabel Tinoco-Méndez, Lucía Macías-Rosales, Francisco
Sánchez-Bartéz, Graciela Guadalupe Tapia-Pérez, Laura Romero-
Romero, and María Isabel Gracia-Mora, Functional Effects of Prebiotic Fructans
in Colon Cancer and Calcium Metabolism in Animal Models,2017 Feb
15. doi: 10.1155/2017/9758982, adapted on August 9,
2023:https://www.hindawi.com/journals/bmri/2017/9758982/
69
162
Marisol Rivera-Huerta, Vania Lorena Lizárraga-Grimes, Ibrahim Guillermo
Castro-Torres, Mabel Tinoco-Méndez, Lucía Macías-Rosales, Francisco
Sánchez-Bartéz, Graciela Guadalupe Tapia-Pérez, Laura Romero-
Romero, and María Isabel Gracia-Mora, Functional Effects of Prebiotic Fructans
in Colon Cancer and Calcium Metabolism in Animal Models,2017 Feb
15. doi: 10.1155/2017/9758982, adapted on August 9,
2023:https://www.hindawi.com/journals/bmri/2017/9758982/
163
Wullaert A., Heyninck K., Beyaert R. Mechanisms of crosstalk between TNF-
induced NF-κB and JNK activation in hepatocytes. Biochemical
Pharmacology. 2006;72(9):1090–1101.
doi: 10.1016/j.bcp.2006.07.003. [PubMed] [CrossRef] [Google Scholar] [Ref
list]
164
Yixuan Li and Edward Seto, HDACs and HDAC Inhibitors in Cancer
Development and Therapy 2016 Oct; 6(10):
a026831.doi: 10.1101/cshperspect.a02683, ADAPTED ON August 12,
2023:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046688
70
171
Kim J.-K., Cho M.L., Karnjanapratum S., Shin I.-S., You S.G. In vitro and in
vivo immunomodulatory activity of sulfated polysaccharides
from Enteromorpha prolifera. International Journal of Biological
Macromolecules. 2011;49(5):1051–1058. [PubMed] [Google Scholar] [Ref list]
172
Tuvaanjav S., Shuqin H., Komata M., Ma C., Kanamoto T., Nakashima H., et
al. Isolation and antiviral activity of water-soluble Cynomorium
songaricum Rupr. polysaccharides. Journal of Asian Natural Products
Research. 2016;18(2):159–171. [PubMed] [Google Scholar] [Ref list]
173
Kwon P.S., Oh H., Kwon S.J., Jin W., Zhang F., Fraser K., et al. Sulfated
polysaccharides effectively inhibit SARS-CoV-2 in vitro. Cell
Discovery. 2020;6(1):1–4. [PMC free article] [PubMed] [Google Scholar] [Ref
list]
174
Daniel E. Koshland,Felix, Haurowitz, The Editors of Encyclopaedia
Britannica, Protein biochemistry (Aug 1, 2023), adapted on August 12,
2023:https://www.britannica.com/science/protein
73
175
Adkins J. N. Toward a human blood serum proteome: analysis by
multidimensional separation coupled with mass spectrometry. Molecular &
Cellular Proteomics. 2002;1:947–955. doi: 10.1074/mcp.m200066-
mcp200. [PubMed] [CrossRef] [Google Scholar] [Ref list]
176
Smith L. M., Kelleher N. L. Proteoform: a single term describing protein
complexity. Nature Methods. 2013;10(3):186–187.
doi: 10.1038/nmeth.2369. [PMC free article] [PubMed] [CrossRef] [Google
Scholar] [Ref list]
177
Singh R.S., Walia A.K., Kennedy J.F. Mushroom lectins in biomedical
research and development. International Journal of Biological
Macromolecules. 2020;151:1340–1350. [PubMed] [Google Scholar] [Ref list]
178
Mazalovska M., Kouokam J.C. Lectins as promising therapeutics for the
prevention and treatment of HIV and other potential coinfections. BioMed
Research International. 2018 doi: 10.1155/2018/3750646. [PMC free
article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
179
Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W.,
Egberink H.…Van Ranst M. Plant lectins are potent inhibitors of coronaviruses
by interfering with two targets in the viral replication cycle. Antiviral
Research. 2007;75(3):179–187. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
74
185
V LAVASTRE, H CAVALLI, C RATTHE, D GIRARD, Anti-inflammatory
effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated
neutrophils and inhibition of lipopolysaccharide-induced neutrophilic
inflammation in vivo, Clinical and Experimental Immunology, Volume 137,
Issue 2, August 2004, Pages 272–278, https://doi.org/10.1111/j.1365-
2249.2004.02545.x (28 June 2004), Adapted on August 13, 2023:
186
Tibor Hajtó,Katarina Hostanska, Timea Berki, László Pálinkás,Ferenc
Boldizsár, and Péter Németh, Oncopharmacological Perspectives of a Plant
Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In
vitro Experiments and In vivo Animal Models, and Their Possible Relevance for
Clinical Applications, 2005 Mar; 2(1): 59–2005 Jan
28. doi: 10.1093/ecam/neh058, adapted on August 13,
2023:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1062151/
76
187
Harvard T.H Chan, School of Public Health, Lectins (January 2022), adapted
on August 12, 2023:https://www.hsph.harvard.edu/nutritionsource/anti-
nutrients/lectins/
188
Das U.N. Arachidonic acid and other unsaturated fatty acids and some of their
metabolites function as endogenous antimicrobial molecules: A review. Journal
of Advanced Research. 2018;11:57–66. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
189
Kohn A., Gitelman J., Inbar M. Interaction of polyunsaturated fatty acids with
animal cells and enveloped viruses. Antimicrobial Agents and
Chemotherapy. 1980;18(6):962–968. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
190
Kohn A., Gitelman J., Inbar M. Interaction of polyunsaturated fatty acids with
animal cells and enveloped viruses. Antimicrobial Agents and
Chemotherapy. 1980;18(6):962–968. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
77
191
Das U.N. Can bioactive lipids inactivate coronavirus (COVID-19)? Archives
of Medical Research. 2020;51(3):282–286. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
192
Das U.N. Arachidonic acid and other unsaturated fatty acids and some of their
metabolites function as endogenous antimicrobial molecules: A review. Journal
of Advanced Research. 2018;11:57–66. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
193
Thormar H., Isaacs C.E., Brown H.R., Barshatzky M.R., Pessolano T.
Inactivation of enveloped viruses and killing of cells by fatty acids and
monoglycerides. Antimicrobial Agents and Chemotherapy. 1987;31(1):27–
31. [PMC free article] [PubMed] [Google Scholar] [Ref list]
194
Schönfeldt H.C., Pretorius B., Hall N. In: Caballero B., Finglas P., F Toldrá
F., editors. Vol. 1. 2016. Bioavailability of nutrients; pp. 401–406. (The
encyclopedia of food and health). [Google Scholar] [Ref list]
195
Gutiérrez S., Svahn S.L., Johansson M.E. Effects of omega-3 fatty acids on
immune cells. International Journal of Molecular Sciences. 2019;20(20):5028.
doi: 10.3390/ijms20205028. [PMC free article] [PubMed] [CrossRef] [Google
Scholar] [Ref list]
196
Sheridan D.A., Bridge S.H., Crossey M.M., Felmlee D.J., Fenwick F.I.,
Thomas H.C.…Bassendine M.F. Omega‐3 fatty acids and/or fluvastatin in
hepatitis C prior non‐responders to combination antiviral therapy–a pilot
randomised clinical trial. Liver International. 2014;34(5):737–
747. [PubMed] [Google Scholar] [Ref list]
78
197
Donatella D, Eliseo and Francesca Velotti, Omega-3 Fatty Acids and Cancer
Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy, J. Clin.
Med. 2016, 5(2), 15; https://doi.org/10.3390/jcm5020015, adapted on August
13, 2023: https://www.mdpi.com/2077-0383/5/2/15
198
Martínez-Soto J.C., Domingo J.C., Cordobilla B., Nicolás M., Fernández L.,
Albero P., Gadea J., Landeras J. Dietary supplementation with docosahexaenoic
acid (DHA) improves seminal antioxidants status and decreases sperm DNA
fragmentation. Syst. Biol. Reprod. Med. 2016;62:387–395.
doi: 10.1080/19396368.2016.1246623. [PubMed] [CrossRef] [Google Scholar].
199
Samadian F., Towhidi A., Rezayadi K., Bahreini M. Effects of dietary n-3
fatty acids on characteristics and lipid composition of ovine sperm. Animals.
2010;4:2017–2022. doi: 10.1017/S1751731110001308. [PubMed] [CrossRef]
[Google Scholar]
79
200
Jabulani Nkululeko Ngcobo, Fhulufhelo Vincent Ramukhithi,Khathutshelo
Agree Nephawe,Takalani Judas Mpofu,Tlou Caswell Chokoe,and
Tshimangadzo Lucky Nedambale, Flaxseed Oil as a Source of Omega n-3 Fatty
Acids to Improve Semen Quality from Livestock Animals: A Review, National
Center for Biotechnology Information (2021 Nov
28):https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698102/
201
Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long
chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J
Nutr. 2012;107(Suppl 2):S201–13. [PubMed] [Google Scholar]
202
Calder PC. The role of marine omega-3 (n-3) fatty acids in inflammatory
processes, atherosclerosis and plaque stability. Mol Nutr Food Res.
2012;56:1073–1080. [PubMed] [Google Scholar]
203
Ajami M, Davoodi SH, Habibey R, Namazi N, Soleimani M, Pazoki-Toroudi
H. Effect of DHA+EPA on oxidative stress and apoptosis induced by ischemia-
reperfusion in rat kidneys. Fundam Clin Pharmacol. 2013;27:593–602.
[PubMed] [Google Scholar]
204
Castillo RL, Arias C, Farías JG. Omega 3 chronic supplementation attenuates
myocardial ischaemia-reperfusion injury through reinforcement of antioxidant
defense system in rats. Cell Biochem Funct. 2014;32:274–281. [PubMed]
[Google Scholar]
80
205
Brahmbhatt V, Oliveira M, Briand M, Perrisseau G, Bastic Schmid V,
Destaillats F, Pace-Asciak C, Benyacoub J, Bosco N. Protective effects of
dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress. J Nutr
Biochem. 2013;24:104–111. [PubMed] [Google Scholar]
206
Avramovic N, Dragutinovic V, Krstic D, Colovic M, Trbovic A, de Luka S,
Milovanovic I, Popovic T. The effects of omega 3 fatty acid supplementation on
brain tissue oxidative status in aged wistar rats. Hippokratia. 2012;16:241–245.
[PMC free article] [PubMed] [Google Scholar]
207
Miles EA, Wallace FA, Calder PC. Dietary fish oil reduces intercellular
adhesion molecule 1 and scavenger receptor expression on murine macrophages.
Atherosclerosis. 2000;152:43–50. [PubMed] [Google Scholar]
208
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Jr, Libby P. The
omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of
proatherogenic and proinflammatory proteins in human endothelial cells.
Arterioscler Thromb. 1994;14:1829–1836. [PubMed] [Google Scholar]
81
209
Calder, P.C. Omega-3 polyunsaturated fatty acids and inflammatory
processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol.2013, 75, 645–
662. [Google Scholar] [CrossRef] [PubMed][Green Version]
210
Ortega-Gómez, A.; Perretti, M.; Soehnlein, O. Resolution of inflammation:
An integrated view. EMBO Mol. Med.2013, 5, 661–674. [Google Scholar]
[CrossRef] [PubMed]
211
Lands, W. Historical perspectives on the impact of n-3 and n-6 nutrients on
health. Prog. Lipid Res. 2014, 55, 17–29. [CrossRef
212
Saidane, O.; Semerano, L.; Sellam, J. Could omega-3 fatty acids prevent
rheumatoid arthritis? Jt. Bone Spine 2019, 86, 9–12. [CrossRef]
213
Ye, Y.; Pang, Z.; Chen, W.; Ju, S.; Zhou, C. The epidemiology and risk
factors of inflammatory bowel disease. Int. J. Clin. Exp. Med. 2015, 8, 22529–
22542
214
Schunck, W.-H.; Konkel, A.; Fischer, R.; Weylandt, K.-H. Therapeutic
potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and
inflammatory diseases. Pharmacol. Ther. 2018, 183, 177–204. [CrossRef
82
222
Oomar D.B. Flaxseed as a functional food source. J. Sci. Food Agric.
2001;81:889–894. [Google Scholar]
223
Francois CA, Connor SL, Bolewicz LC, Connor WE. Supplementing
lactating women with flaxseed oil does not increase docosahexaenoic acid in
their milk. Am J Clin Nutr 2003;77:226-33.
224
Jabulani Nkululeko Ngcobo, Fhulufhelo Vincent Ramukhithi,Khathutshelo
Agree Nephawe,Takalani Judas Mpofu,Tlou Caswell Chokoe,and
Tshimangadzo Lucky Nedambale, Flaxseed Oil as a Source of Omega n-3 Fatty
Acids to Improve Semen Quality from Livestock Animals: A Review, National
Center for Biotechnology Information (2021 Nov
28):https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698102/
84
225
Yu W, Zhao Y, Chen J, Shu B. Comparison of twokinds of pumpkinseed oils
obtained by supercritical CO2 extraction. Eur J Lipid SciTechnol
2004;106(6):355-8.
226
Applequist WL, Avula B, Schaneberg BT, Wang YH, Khan IA.Comparative
fatty acid content of seeds of four Cucurbita speciesgrown in a common (shared)
garden. J Food Compos Anal 2006,19 (6-7): 606-611.
227
Zanussi H.P., Shariatmadari F., Sharafi M., Ahmadi H. Dietary
supplementation with flaxseed oil as source of omega-3 fatty acids improves
seminal quality and reproduction performance in aged broiler breeder roosters.
Theriogenology. 2019;130:41–48. doi: 10.1016/j.theriogenology.2019.02.030.
[PubMed] [CrossRef] [Google Scholar]
228
Innes J.K., Calder P.C. Marine omega-3 (N-3) fatty acids for cardiovascular
health: And update for 2020. Int. J. Mol. Sci. 2020;21:1362.
doi: 10.3390/ijms21041362. [PMC free article] [PubMed] [CrossRef] [Google
Scholar]
229
Khan H.K., Qureshi M.S., Khan I., Rehman S., Mehsud T., Ullah I., Aftab M.,
Rehman F. Dietary flaxseed oil supplementation effect on bovine semen quality
parameters. Vet. J. 2015;3:9–13. [Google Scholar]
230
Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect
on human tumor necrosis factor alpha and interleukin 1 beta production of diets
enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr
1996;63:116-22.
85
235
Mullin G.E. Vitamin A and immunity. Nutrition in Clinical
Practice. 2011;26(4):495–496. [PubMed] [Google Scholar] [Ref list]
236
Liang Y., Yi P., Wang X., Zhang B., Jie Z., Soong L., et al. Retinoic acid
modulates hyperactive T cell responses and protects vitamin a–deficient mice
against persistent lymphocytic choriomeningitis virus infection. The Journal of
Immunology. 2020;204(11):2984–2994. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
237
Ralph R. Weichselbaum, MD, Derivative of Vitamin A enhances the tumor-
killing effectiveness of radiotherapy (June 21, 2021), adapted on August 13,
2023:https://www.uchicagomedicine.org/forefront/cancer-articles/derivative-of-
vitamin-a-enhances-tumor-killing-effectiveness
87
238
Vera, J. C., Rivas, C. I., Fischbarg, J., and Golde, D. W. (1993). Mammalian
facilitative hexose transporters mediate the transport of dehydroascorbic acid.
Nature 364, 79–82. doi: 10.1038/364079a0
88
239
Francisco J. Roa, Eduardo Peña, Marcell Gatica Kathleen Escobar-
Acuña,Paulina Saavedra,Mafalda Maldonado,Magdalena E. Cuevas,Gustavo
Moraga-Cid,Coralia I. Rivas,and Carola Muñoz-Montesino,Therapeutic Use of
Vitamin C in Cancer: Physiological Considerations, Forontiers in
Pharmacologie,(Marc 2020, volume 11, 21), adapted on August 13,
2023:file:///C:/Users/Owner/Downloads/fphar-11-00211.pdf
240
McCormick W. J. (1959). Cancer: a collagen disease, secondary to a
nutritional deficiency. Arch. Pediatr. 76 166–171. [PubMed] [Google
Scholar] [Ref list]
241
Cameron E., Rotman D. (1972). Ascorbic acid, cell proliferation, and
cancer. Lancet 1:542 10.1016/s0140-6736(72)90215-2 [PubMed]
[CrossRef] [Google Scholar] [Ref list
242
Cameron E., Campbell A., Jack T. (1975). The orthomolecular treatment of
cancer. III. Reticulum cell sarcoma: double complete regression induced by
high-dose ascorbic acid therapy. Chem. Biol. Interact 11 387–393.
[PubMed] [Google Scholar] [Ref list]
89
252
Klotman M.E., Chang T.L. Defensins in innate antiviral immunity. Nature
Reviews Immunology. 2006;6(6):447–456. [PubMed] [Google Scholar] [Ref list]
253
Cannell J., Vieth R., Umhau J., Holick M., Grant W., Madronich
S.…Giovannucci E. Epidemic influenza and vitamin D. Epidemiology and
Infection. 2006;134(6):1129–1140. [PMC free article] [PubMed] [Google
Scholar] [Ref list]
254
Akimbekov N.S., Ortoski R.A., Razzaque M.S. Effects of sunlight exposure
and vitamin D supplementation on HIV patients. The Journal of Steroid
Biochemistry and Molecular Biology. 2020:105664.
doi: 10.1016/j.jsbmb.2020.105664. [PubMed] [CrossRef] [Google Scholar] [Ref
list]
255
Schwalfenberg G.K. A review of the critical role of vitamin D in the
functioning of the immune system and the clinical implications of vitamin D
deficiency. Molecular Nutrition & Food Research. 2011;55(1):96–
108. [PubMed] [Google Scholar] [Ref list]
256
Schwalfenberg G.K. A review of the critical role of vitamin D in the
functioning of the immune system and the clinical implications of vitamin D
deficiency. Molecular Nutrition & Food Research. 2011;55(1):96–
108. [PubMed] [Google Scholar] [Ref list]
93
257
Hewison M. Vitamin D and the immune system: New perspectives on an old
theme. Rheumatic Disease Clinics. 2012;38(1):125–139. [PubMed] [Google
Scholar] [Ref list]
258
Mocanu V., Stitt P.A., Costan A.R., Voroniuc O., Zbranca E., Luca V., et al.
Long-term effects of giving nursing home residents bread fortified with 125 μg
(5000 IU) vitamin D3 per daily serving. American Journal of Clinical
Nutrition. 2009;89(4):1132–1137. [PubMed] [Google Scholar] [Ref list]
259
Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano
J.L., et al. Vitamin D supplementation could prevent and treat influenza,
coronavirus, and pneumonia infections. PrePrints. 2020
doi: 10.20944/preprints202003.0235.v1. [PMC free article] [PubMed]
[CrossRef] [Google Scholar] [Ref list]
260
Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a
common proregion an a variable C-terminal antimicrobial domain. FEBS
Lett. 1995;374:1–5. [PubMed] [Google Scholar] [Ref list]
261
Zanetti M. The role of cathelicidins in the innate host defenses of
mammals. Curr Issues Mol Biol. 2005;7:179–196. [PubMed] [Google
Scholar] [Ref list]
262
Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL,
Aguilar-Leon D, et al. Expression of cathelicidin LL-37 during Mycobacterium
tuberculosis infection in human alveolar macrophages, monocytes, neutrophils,
and epithelial cells. Infect Immun (2008) 76(3):935–41. doi:10.1128/IAI.01218-
07
94
263
Gudmundsson GH, Magnusson KP, Chowdhary BP, Johansson M, Andersson
L, Boman HG. Structure of the gene for porcine peptide antibiotic PR-39, a
cathelin gene family member: comparative mapping of the locus for the human
peptide antibiotic FALL-39. Proc Natl Acad Sci USA. 1995;92:7085–
7089. [PMC free article] [PubMed] [Google Scholar] [Ref list]
264
Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-
18 is expressed in epithelia of the human lung where it has broad antimicrobial
activity at the airway surface. Proc Natl Acad Sci USA. 1998;95:9541–
9546. [PMC free article] [PubMed] [Google Scholar] [Ref list]
265
Frohm A, Agerberth B, Ahangari G, Stahle-Backdahl M, Linden S, Wigzell
H, Gudmundsson GH. The expression of the gene coding for the antibacterial
peptide LL-37 is induced in human keratinocytes during inflammatory
disorders. J Biol Chem. 1997;272:15258–15263. [PubMed] [Google
Scholar] [Ref list]
266
Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL,
Aguilar-Leon D, Torres M, Sada E. Expression of cathelicidin LL-37
during Mycobacterium tuberculosis infection in human alveolar macrophages,
monocytes, neutrophils, and epithelial cells. Infect Immun. 2008;76:935–
941. [PMC free article] [PubMed] [Google Scholar] [Ref list]
95
267
Lora V. Hooper, Epithelial Cell Contributions to Intestinal
Immunity, Advances in Immunology (2015), adapted on August 16, 2023:
https://www.sciencedirect.com/topics/neuroscience/cathelicidin#:~:text=Catheli
cidins%20are%20a%20third%20general,%2C%20%26%20Kagnoff%2C%2020
02).
268
Jing Shen, Zhangang Xiao,Cathelicidin in Gastrointestinal Disorders,
Antimicrobial Peptides in Gastrointestinal Diseases (2018), adapted on adapted
on August 16, 2023:
https://www.sciencedirect.com/topics/neuroscience/cathelicidin#:~:text=Catheli
cidins%20are%20a%20third%20general,%2C%20%26%20Kagnoff%2C%2020
02).
269
Zhu Zhang, Wen-Qing Chen, Shi-Qing Zhang, Jing-Xuan Bai, Ching-Lam
Lau, Stephen Cho-Wing Sze, Ken Kin-Lam Yung, and Joshua Ka-Shun Ko,The
human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by
suppressing autophagy and reprogramming of the tumor immune
microenvironment,2022 Jul 22. doi: 10.3389/fphar.2022.906625, adapted on
August 15, 2023:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355328/
96
270
Ren S. X., Cheng A. S., To K. F., Tong J. H., Li M. S., Shen J., et al.
(2012). Host immune defense peptide LL-37 activates caspase-independent
apoptosis and suppresses colon cancer. Cancer Res. 72 (24), 6512–6523.
10.1158/0008-5472.CAN-12-2359 PubMed Abstract | 10.1158/0008-
5472.CAN-12-2359 | Google Scholar [PMC free article] [PubMed] [CrossRef]
[CrossRef] [Google Scholar] [Ref list]
271
Kuroda K., Fukuda T., Krstic-Demonacos M., Demonacos C., Okumura K.,
Isogai H., et al. (2017). miR-663a regulates growth of colon cancer cells, after
administration of antimicrobial peptides, by targeting CXCR4-p21
pathway. BMC Cancer 17 (1), 33. 10.1186/s12885-016-3003-9 PubMed
Abstract | 10.1186/s12885-016-3003-9 | Google Scholar [PMC free
article] [PubMed] [CrossRef] [CrossRef] [Google Scholar] [Ref list]
272
Wu W. K. K., Sung J. J. Y., To K. F., Yu L., Li H. T., Li Z. J., et al.
(2010). The host defense peptide LL‐37 activates the tumor‐suppressing bone
morphogenetic protein signaling via inhibition of proteasome in gastric cancer
cells. J. Cell. Physiol. 223 (1), 178–186. 10.1002/jcp.22026 PubMed Abstract |
10.1002/jcp.22026 | Google Scholar [PubMed] [CrossRef] [CrossRef] [Google
Scholar] [Ref list]
273
Mader J. S., Mookherjee N., Hancock R. E., Bleackley R. C. (2009). The
human host defense peptide LL-37 induces apoptosis in a calpain-and apoptosis-
inducing factor–dependent manner involving bax activity. Mol. Cancer
Res. 7 (5), 689–702. 10.1158/1541-7786.MCR-08-0274 PubMed Abstract |
10.1158/1541-7786.MCR-08-0274 | Google Scholar [PubMed] [CrossRef]
[CrossRef] [Google Scholar] [Ref list]
274
Chen X., Qi G., Qin M., Zou Y., Zhong K., Tang Y., et al. (2017). DNA
methylation directly downregulates human cathelicidin antimicrobial peptide
gene (CAMP) promoter activity. Oncotarget 8 (17), 27943–27952.
10.18632/oncotarget.15847 PubMed Abstract | 10.18632/oncotarget.15847
| Google Scholar [PMC free article] [PubMed] [CrossRef] [CrossRef] [Google
Scholar] [Ref list]
275
Sainz B., Alcala S., Garcia E., Sanchez-Ripoll Y., Azevedo M. M., Cioffi M.,
et al. (2015). Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal
adenocarcinoma by activating its cancer stem cell compartment. Gut 64 (12),
1921–1935. 10.1136/gutjnl-2014-308935 PubMed Abstract | 10.1136/gutjnl-
2014-308935 | Google Scholar [PubMed] [CrossRef] [CrossRef] [Google
Scholar] [Ref list]
97
276
Coffelt S. B., Waterman R. S., Florez L., Bentrup K. H. Z., Zwezdaryk K. J.,
Tomchuck S. L., et al. (2008). Ovarian cancers overexpress the antimicrobial
protein hCAP‐18 and its derivative LL‐37 increases ovarian cancer cell
proliferation and invasion. Int. J. Cancer 122 (5), 1030–1039.
10.1002/ijc.23186 PubMed Abstract | 10.1002/ijc.23186 | Google
Scholar [PubMed] [CrossRef] [CrossRef] [Google Scholar] [Ref list]
277
von Haussen J., Koczulla R., Shaykhiev R., Herr C., Pinkenburg O., Reimer
D., et al. (2008). The host defence peptide LL-37/hCAP-18 is a growth factor
for lung cancer cells. Lung Cancer 59 (1), 12–23.
10.1016/j.lungcan.2007.07.014 PubMed Abstract |
10.1016/j.lungcan.2007.07.014 | Google Scholar [PubMed] [CrossRef]
[CrossRef] [Google Scholar] [Ref list]
278
Weber G., Chamorro C. I., Granath F., Liljegren A., Zreika S., Saidak Z., et
al. (2009). Human antimicrobial protein hCAP18/LL-37 promotes a metastatic
phenotype in breast cancer. Breast Cancer Res. 11 (1), R6.
10.1186/bcr2221 PubMed Abstract | 10.1186/bcr2221 | Google Scholar [PMC
free article] [PubMed] [CrossRef] [CrossRef] [Google Scholar] [Ref list]
279
Hensel J. A., Chanda D., Kumar S., Sawant A., Grizzle W. E., Siegal G. P., et
al. (2011). LL‐37 as a therapeutic target for late stage prostate
cancer. Prostate 127 (6), 659–670. 10.1002/pros.21282 PubMed Abstract |
10.1002/pros.21282 | Google Scholar [PMC free article] [PubMed] [CrossRef]
[CrossRef] [Google Scholar] [Ref list]
280
Hensel J. A., Chanda D., Kumar S., Sawant A., Grizzle W. E., Siegal G. P., et
al. (2011). LL‐37 as a therapeutic target for late stage prostate
cancer. Prostate 127 (6), 659–670. 10.1002/pros.21282 PubMed Abstract |
10.1002/pros.21282 | Google Scholar [PMC free article] [PubMed] [CrossRef]
[CrossRef] [Google Scholar] [Ref list]
281
Jia J., Zheng Y., Wang W., Shao Y., Li Z., Wang Q., et al.
(2017). Antimicrobial peptide LL-37 promotes YB-1 expression, and the
viability, migration and invasion of malignant melanoma cells. Mol. Med.
Rep. 15 (1), 240–248. 10.3892/mmr.2016.5978 PubMed Abstract |
10.3892/mmr.2016.5978 | Google Scholar [PMC free article] [PubMed]
[CrossRef] [CrossRef] [Google Scholar] [Ref list]
282
Wang W., Zheng Y., Jia J., Li C., Duan Q., Li R., et al. (2017). Antimicrobial
peptide LL-37 promotes the viability and invasion of skin squamous cell
carcinoma by upregulating YB-1. Exp. Ther. Med. 14 (1), 499–506.
98
288
Ju J, Picinich SC, Yang Z, et al. Cancer-preventive activities of tocopherols
and tocotrienols. Carcinogenesis. 2010;31(4):533–542. [PMC free
article] [PubMed] [Google Scholar] [Ref list]
289
Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of
cardiovascular disease and cancer: the Women‘s Health Study: a randomized
controlled trial. JAMA. 2005;294(1):56–65. [PubMed] [Google Scholar]
290
Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the
prevention of prostate and total cancer in men: the Physicians‘ Health Study II
randomized controlled trial. JAMA. 2009;301(1):52–62. [PMC free
article] [PubMed] [Google Scholar]
291
Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin
E on risk of prostate cancer and other cancers: the Selenium and Vitamin E
Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39–51. [PMC free
100
294
Qing Jiang,Natural Forms of Vitamin E as Effective Agents for Cancer
Prevention and Therapy,Advances in Nutrition, Volume 8, Issue 6, November
2017, Pages 850-867, adapted on August 16, 2023:
https://www.sciencedirect.com/science/article/pii/S2161831322008183
295
LJ Marnett Aspirin and the potential role of prostaglandins in colon cancer
Cancer Res, 52 (1992), pp. 5575-5589
296
MM Taketo Cyclooxygenase-2 inhibitors in tumorigenesis (part II) J Natl
Cancer Inst, 90 (1998), pp. 1609-1620
297
MM Taketo Cyclooxygenase-2 inhibitors in tumorigenesis (part I) J Natl
Cancer Inst, 90 (1998), pp. 1529-1536
298
F Cianchi, C Cortesini, L Magnelli, E Fanti, L Papucci, N Schiavone, L Mess
erini, A Vannacci, S Capaccioli, F Perna, et al.Inhibition of 5-lipoxygenase by
MK886 augments the antitumor activity of celecoxib in human colon cancer
cells Mol Cancer Ther, 5 (2006), pp. 2716-2726
299
S Gupta, M Srivastava, N Ahmad, K Sakamoto, DG Bostwick, H Mukhtar
Lipoxygenase-5 is overexpressed in prostate adenocarcinoma Cancer, 91 (2001),
pp. 737-743
300
LG Melstrom, DJ Bentrem, MR Salabat, TJ Kennedy, XZ Ding, M Strouch, S
M Rao, RC Witt, CA Ternent, MS Talamonti, RH Bell, TA AdriannOverexpress
ion of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX
inhibitors in vitro and in a murine model Clin Cancer Res, 14 (2008), pp. 6525-
6530
301
102
302
D Wang, RN Dubois Eicosanoids and cancer Nat Rev Cancer, 10 (2010),
pp. 181-193
303
CH Liu, SH Chang, K Narko, OC Trifan, MT Wu, E Smith, C Haudenschild,
TF Lane, T Hla Overexpression of cyclooxygenase-2 is sufficient to induce
tumorigenesis in transgenic mice J Biol Chem, 276 (2001), pp. 18563-18569
304
K Narko, A Ristimaki, M MacPhee, E Smith, CC Haudenschild, T Hla
Tumorigenic transformation of immortalized ECV endothelial cells by
cyclooxygenase-1 overexpression J Biol Chem, 272 (1997), pp. 21455-21460
305
M Tsujii, S Kawano, S Tsuji, H Sawaoka, M Hori, RN DuBois
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Cell, 93 (1998), pp. 705-716
306
S Harada, JA Nagy, KA Sullivan, KA Thomas, N Endo, GA Rodan, SB Roda
n Induction of vascular endothelial growth factor expression by prostaglandin
E2 and E1 in osteoblasts J Clin Invest, 93 (1994), pp. 2490-2496
307
RF Jacoby, K Seibert, CE Cole, G Kelloff, RA Lubet The cyclooxygenase-2
inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse
model of adenomatous polyposis Cancer Res, 60 (2000), pp. 5040-5044
308
T Kawamori, CV Rao, K Seibert, BS Reddy Chemopreventive activity of
celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
Cancer Res, 58 (1998), pp. 409-412
309
Q Jiang, I Elson-Schwab, C Courtemanche, BN Ames gamma-Tocopherol
and its major metabolite, in contrast to alpha- tocopherol, inhibit
103
cyclooxygenase activity in macrophages and epithelial cells Proc Natl Acad Sci
USA, 97 (2000), pp. 11494-11499
310
Q Jiang, X Yin, MA Lill, ML Danielson, H Freiser, J Huang Long-chain
carboxychromanols, metabolites of vitamin E, are potent inhibitors of
cyclooxygenases Proc Natl Acad Sci USA, 105 (2008), pp. 20464-20469
311
SI Grivennikov, FR Greten, M Karin Immunity, inflammation, and cancer
Cell, 140 (2010), pp. 883-899
312
B Sun, M Karin The therapeutic value of targeting inflammation in
gastrointestinal cancers Trends Pharmacol Sci, 35 (2014), pp. 349-357
313
S Grivennikov, E Karin, J Terzic, D Mucida, GY Yu, S Vallabhapurapu, J Sc
heller, S Rose-John, H Cheroutre, L Eckmann, et al. IL-6 and Stat3 are required
for survival of intestinal epithelial cells and development of colitis-associated
cancer Cancer Cell, 15 (2009), pp. 103-113
314
FR Greten, L Eckmann, TF Greten, JM Park, ZW Li, LJ Egan, MF Kagnoff,
M Karin IKKbeta links inflammation and tumorigenesis in a mouse model of
colitis-associated cancer Cell, 118 (2004), pp. 285-296
315
Q Jiang Natural forms of vitamin E: metabolism, antioxidant, and anti-
inflammatory activities and their role in disease prevention and therapy Free
Radic Biol Med, 72 (2014), pp. 76-90
104
317
Gombart A.F., Pierre A., Maggini S. A review of micronutrients and the
immune system–Working in harmony to reduce the risk of
infection. Nutrients. 2020;12(1):236. doi: 10.3390/nu12010236. [PMC free
article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
318
Gao H., Dai W., Zhao L., Min J., Wang F. The role of zinc and zinc
homeostasis in macrophage function. Journal of Immunology Research. 2018
doi: 10.1155/2018/6872621. [PMC free article] [PubMed] [CrossRef] [Google
Scholar] [Ref list]
106
319
Alpert P.T. The role of vitamins and minerals on the immune system. Home
Health Care Management & Practice. 2017;29(3):199–202. [Google
Scholar] [Ref list]
320
C Andreini, I Bertini A bioinformatics view of zinc enzymes J Inorg
Biochem, 111 (2012), pp. 150-156
321
S Overbeck, L Rink, H Haase Modulating the immune response by oral zinc
supplementation: a single approach for multiple diseases Arch Immunol Ther
Exp (Warsz), 56 (1) (2008), pp. 15-30
322
P Babula, M Masarik, V Adam, T Eckschlager, M Stiborova, L Trnkova, H S
kutkova, I Provaznik, J Hubalek, R Kizek Mammalian metallothioneins:
properties and functions Metallomics, 4 (8) (2012), pp. 739-750
107
334
WJ Kent, CW Sugnet, TS Furey, KM Roskin, TH Pringle, AM Zahler, D Hau
ssler The human genome browser at UCSC Genome Res, 12 (6) (2002), pp. 996-
1006
335
Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr
Biochem. 2004;15:572–8. [PubMed] [Google Scholar] [Ref list]
336
Ho E, Courtemanche C, Ames BN. Zinc deficiency induces oxidative DNA
damage and increases p53 expression in human lung fibroblasts. J
Nutr. 2003;133:2543–8. [PubMed] [Google Scholar]
337
Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage,
disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a
rat glioma cell line. Proc Natl Acad Sci USA. 2002;99:16770–5. [PMC free
article] [PubMed] [Google Scholar]
110
353
Gelen V, Şengül E, Yıldırım S, et al. The protective effects of hesperidin and
curcumin on 5-fluorouracil–induced nephrotoxicity in mice. Environmental
Science and Pollution Research. 2021;28:47046-47055
354
Santesmasses D, Mariotti M, Gladyshev VN. Bioinformatics of
selenoproteins. Antioxidants & Redox Signaling. 2020;33:525-536
355
Gelen V, Şengül E, Yıldırım S, Atila G. The protective effects of naringin
against 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats. Iranian
Journal of Basic Medical Sciences. 2018;21(4):404-410
356
Arbogast S, Ferreiro A. Selenoproteins and protection against oxidative stress:
Selenoprotein N as a novel player at the crossroads of redox signaling and
calcium homeostasis. Antioxidants & Redox Signaling. 2010;12:893-904
357
Gelen V, Yıldırım S, Şengül E, Çınar A, Çelebi F, Küçükkalem M, et al.
Naringin attenuates oxidative stress, inflammation, apoptosis, and oxidative
DNA damage in acrylamide-induced nephrotoxicity in rats. Asian Pacific
Journal of Tropical Biomedicine. 2022;12:223-232
358
Sengul E, Gelen V, Yildirim S, Cinar İ, Aksu EH. Effects of naringin on
oxidative stress, inflammation, some reproductive parameters, and apoptosis in
acrylamide-induced testis toxicity in rat. Environmental Toxicology.
2023;38(4):798-808
359
Olivia Guillin, Implication du sélénium et des isotopes du zinc lors de
l’infection par le VIH-1 (2021), adapted on August 20, 2023 :
https://theses.hal.science/tel-03893427/
114
360
Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD. Diverse effects of
methylseleninic acid on the transcriptional program of human prostate cancer
cells. Mol Biol Cell. 2004;15:506–519. doi: 10.1091/mbc.E03-07-0501. [PMC
free article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
361
Dong Y, Ganther HE, Stewart C, Ip C. Identification of molecular targets
associated with selenium-induced growth inhibition in human breast cells using
cDNA microarrays. Cancer Res. 2002;62:708–714. [PubMed] [Google
Scholar] [Ref list]
362
Björkhem-Bergman L, Torndal UB, Eken S, Nyström C, Capitanio A, Larsen
EH, et al. Selenium prevents tumor development in a rat model for chemical
carcinogenesis. Carcinogenesis. 2005;26:125–131.
doi: 10.1093/carcin/bgh290. [PubMed] [CrossRef] [Google Scholar] [Ref list]
363
Nilsonne G, Sun X, Nyström C, Rundlöf AK, Fernandes AP, Björnstedt M, et
al. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells
through oxidative stress. Free Radic Biol Med. 2006;41:874–885.
doi: 10.1016/j.freeradbiomed.2006.04.031. [PubMed] [CrossRef] [Google
Scholar] [Ref list]
364
Husbeck B, Nonn L, Peehl DM, Knox SJ. Tumor-selective killing by selenite
in patient-matched pairs of normal and malignant prostate
cells. Prostate. 2006;66:218–225. doi: 10.1002/pros.20337. [PubMed]
[CrossRef] [Google Scholar] [Ref list]
115
365
Olm E, Fernandes AP, Hebert C, Rundlof AK, Larsen EH, Danielsson O, et
al. Extracellular thiol-assisted selenium uptake dependent on the x(c)- cystine
transporter explains the cancer-specific cytotoxicity of selenite. Proc Natl Acad
Sci U S A. 2009;106:11400–11405. doi: 10.1073/pnas.0902204106. [PMC free
article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
366
Yan L, Yee JA, McGuire MH, Graef GL. Effect of dietary supplementation of
selenite on pulmonary metastasis of melanoma cells in mice. Nutr
Cancer. 1997;28:165–169. doi: 10.1080/01635589709514570. [PubMed]
[CrossRef] [Google Scholar] [Ref list]
367
Janis Fleming, Aurnab Ghose&Paul R. Harrison,Molecular Mechanisms of
Cancer Prevention by Selenium Compounds, Pages 42-49 | Published online:
18 Nov 2009, adapted on August 20, 2023:
https://www.tandfonline.com/doi/abs/10.1207/S15327914
368
Gul-e-Saba Chaudhry1 bdah Md Akim, Yeong Yik Sung, Tengku Muhammad
Tengku Sifzizul,Cancer and apoptosis: The apoptotic activity of plant and
marine natural products and their potential as targeted cancer therapeutics,
August 2022 DOI 10.3389/fphar.2022.842376, adapted on August 21, 2023:
file:///C:/Users/Owner/Downloads/fphar-13-842376.pdf
116
371
Vincent M., Duval R.E., Hartemann P., Engels‐Deutsch M. Contact killing
and antimicrobial properties of copper. Journal of Applied
Microbiology. 2018;124(5):1032–1046. [PubMed] [Google Scholar] [Ref list]
372
Shah K.K., Verma R., Oleske J.M., Scolpino A., Bogden J.D. Essential trace
elements and progression and management of HIV-1 infection. Nutrition
Research. 2019;71:21–29. [PubMed] [Google Scholar] [Ref list]
373
Vincent M., Duval R.E., Hartemann P., Engels‐Deutsch M. Contact killing
and antimicrobial properties of copper. Journal
of Applied Microbiology. 2018;124(5):1032–1046. [PubMed] [Google
Scholar] [Ref list]
118
Chapitre V :
374
Raguz S, Yague E. Resistance to chemotherapy: New treatments and novel
insights into an old problem. Br J Cancer. 2008;99(3):387–91. doi:
10.1038/sj.bjc.6604510. [PubMed: 18665178]. [PubMed Central:
PMC2527800].
375
Negin Nokhandani, Arash Poursheikhani, Mahdieh Naghavi
Alhosseini, Homa Davoodi, Bacteria in Carcinogenesis and Cancer Prevention:
A Review Study (March 1, 2021), adapted on August 3, 2023:
https://brieflands.com/articles/ijcm-107956.pdf
376
Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv
Drug Deliv Rev. 2001;46(1-3):149–68. doi: 10.1016/s0169- 409x(00)00131-9.
[PubMed: 11259838].
119
ont été isolées des feuilles, des tiges et des graines des
plantes Annonaceae (Papayer, graviola ou corossolier,
etc.). Ces acétogénines ont exhibé leurs effets
cytotoxiques (Capables de détruire les cellules) sur les
différentes lignées cellulaires des cancers humains, y
compris le cancer des poumons, des reins, du colon, des
reins, du pancréas, du foie et de la
383 384 385 386 387 388 389 390
vessie. , , , , , , ,
407
Simon, S.M. and Schindler, M. (1994) Cell biological mechanisms of
multidrug resistance in tumors, Proc. Natl. Acad. Sci. USA, 91, 3497-3504.
408
Ruetz, S. and Gros, P. (1994) A mechanism for P-glycoprotein action in
multidrug resistance: are we there yet?, Trends Pharm. Sci, 15, 260-263.
409
Gottesman, M.M., Ambudkar, S.V., Ni, B., Arnn, J.M., Sugimotto, Y.,
Cardarelli, C.O. and Pastan, I. (1994) Exploiting multidrug resistance to treat
cancer, Cold Spring Harb. Symp. Quant. Biol., 59, 677-683.
410
Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance
mediated by the multidrug transporter, Annu. Rev. Biochem., 62, 385-427.
411
Ling, V. (1992) P-Glycoprotein and resistance to anticancer drugs, Cancer
Res., 69, 2603- 2609.
412
Nicholas H. Oberlies, Vicki L. Croy, Marietta L. Harrison, and Jerry L.
McLaughlin, The Annonaceous Acetogenin Bullatacin Is Cytotoxic against
Multidrug Resistant Human Mammary Adenocarcinoma Cells,Cancer
LettersVolume 115, Issue 1, 1 May 1997, Pages 73-79, adapted on August 30,
2023: http://libres.uncg.edu/ir/uncg/f/N_Oberlies_Annonaceous_1997.pdf
125
413
Proceedings of International Conference on Drug Discovery (ICDD) 202,
Computational Investigations on Reversal Effect of Acetogenins on Multidrug
Resistance Mediated by ABCB1, (7 Feb
2020):https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3532377
414
Simon, S.M. and Schindler, M. (1994) Cell biological mechanisms of
multidrug resistance in tumors, Proc. Natl. Acad. Sci. USA, 91, 3497-3504.
415
Ruetz, S. and Gros, P. (1994) A mechanism for P-glycoprotein action in
multidrug resistance: are we there yet?, Trends Pharm. Sci, 15, 260-263.
416
Gottesman, M.M., Ambudkar, S.V., Ni, B., Arnn, J.M., Sugimotto, Y.,
Cardarelli, C.O. and Pastan, I. (1994) Exploiting multidrug resistance to treat
cancer, Cold Spring Harb. Symp. Quant. Biol., 59, 677-683.
417
Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance
mediated by the multidrug transporter, Annu. Rev. Biochem., 62, 385-427.
418
Ling, V. (1992) P-Glycoprotein and resistance to anticancer drugs, Cancer
Res., 69, 2603- 2609.
126
419
Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of
ATP-dependent transporters. Nat. Rev. Cancer. 2002;2:48–
58. doi:10.1038/nrc706 [PubMed] [Google Scholar] [Ref list]
420
Liaw CC, Chang FR, Lin CY, et al. New cytotoxic monotetrahydrofuran
Annonaceous Acetogenins from Annona muricata. Journal of 112 IMJM
Volume 17 No. 3, December 2018 natural products 2002;65(4):470-475
421
Torres MP, Rachagani S, Purohit V, et al. Graviola: a novel promising
natural-derived drug that inhibits tumorigenicity and metastasis of
pancreatic cancer cells in vitro and in vivo through altering cell
metabolism. Cancer letters 2012;323(1):29-40.
127
437
Jing ZhanG, Hongyan Zhou, Sheng Jiang, Jiayi Jin, Weihua Li, Wencong Wa
ng, Shao Bo Su, AA092, an annonaceous acetogenin mimetic, attenuates
angiogenesis in a mouse model of inflammation-induced corneal
neovascularization,International Immunopharmacology, Volume 28, Issue
2, October 2015, Pages 997-1002, adapted on September 14, 2023:
https://www.sciencedirect.com/science/article/abs/pii/S1567576915300679
438
Veena Coothankandaswamy,Yang Liu,Shui-Chun Mao,J. Brian
Morgan,Fakhri Mahdi,Mika B. Jekabsons,Dale G. Nagle,and Yu-Dong Zhou,
The Alternative Medicine Pawpaw and Its Acetogenin Constituents Suppress
Tumor Angiogenesis via the HIF-1/VEGF Pathway, J Nat Prod. 2010 May 28;
73(5): 956–961. doi: 10.1021/np100228d, adapted on August 29,
2023:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890309/
131
439
Coria-Téllez AV, Montalvo-Gónzalez E, Yahia EM, Obledo-Vázquez EN.
Annona muricata: a comprehensive review on its traditional medicinal uses,
phytochemicals, pharmacological activities, mechanisms of action and toxicity.
Arab J Chem. 2018;11(5):662–91.
440
Oberlies NH, Jones JL, Corbett TH, Fotopoulos SS, McLaughlin JL. Tumor
cell growth inhibition by several Annonaceous acetogenins in an in vitro disk
diffusion assay. Cancer Lett. 1995;96(1):55–62.
441
Yuan SS, Chang HL, Chen HW, Yeh YT, Kao YH, Lin KH, Wu YC, Su JH.
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1
phase and causes cytotoxicity in a Bax- and caspase-3-related pathway. Life Sci.
2003;72(25):2853–61.
442
Ko YM, Wu TY, Wu YC, Chang FR, Guh JY, Chuang LY. Annonacin
induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-
alfa-related pathways in MCF-7 cells. J Ethnopharmacol. 2011;137(3):1283–90.
443
Poon E, Harris AL, Ashcroft M. Expert Rev. Mol.
Med. 2009;11:e26. [PubMed] [Google Scholar]
444
Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell
death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97–111.
doi: 10.1038/nri.2016.107. [PubMed] [CrossRef] [Google Scholar]
445
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, et al.
Consensus guidelines for the definition, detection and interpretation of
immunogenic cell death. J Immunother Cancer. 2020;8(1):e000337. [PMC free
132
article] [PubMed]
446
Li X. The inducers of immunogenic cell death for tumor
immunotherapy. Tumori. 2018;104(1):1–8. doi: 10.5301/tj.5000675. [PubMed]
[CrossRef] [Google Scholar]
447
Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele
P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer.
2012;12(12):860–75. 10.1038/nrc3380. [PubMed]
448
Radogna F, Dicato M, Diederich M. Natural modulators of the hallmarks of
immunogenic cell death. Biochem Pharmacol. 2019;162:55–70.
doi: 10.1016/j.bcp.2018.12.016. [PubMed] [CrossRef] [Google Scholar] [Ref
list]
449
Diederich M. Natural compound inducers of immunogenic cell death. Arch
Pharm Res. 2019;42(7):629–645. doi: 10.1007/s12272-019-01150-z. [PubMed]
[CrossRef] [Google Scholar] [Ref list]
450
Ahammadsahib KI, Hollingworth RM, McGovren JP, Hui YH, McLaughlin
JL. Mode of action of bullatacin: a potent antitumor and pesticidal annonaceous
acetogenin. Life Sci. 1993;53(14):1113–1120. doi: 10.1016/0024-
3205(93)90547-G. [PubMed] [CrossRef] [Google Scholar]
451
Chih HW, Chiu HF, Tang KS, Chang FR, Wu YC. Bullatacin, a potent
antitumor annonaceous acetogenin, inhibits proliferation of human
hepatocarcinoma cell line 2.2.15 by apoptosis induction. Life
Sci. 2001;69(11):1321–1331. doi: 10.1016/S0024-3205(01)01209-7. [PubMed]
[CrossRef] [Google Scholar]
452
Liang YJ, Zhang X, Dai CL, Zhang JY, Yan YY, Zeng MS, Chen LM, Fu
LW. Bullatacin triggered ABCB1-overexpressing cell apoptosis via the
mitochondrial-dependent pathway. J Biomed Biotechnol. 2009;2009:867123.
doi: 10.1155/2009/867123. [PMC free article] [PubMed] [CrossRef] [Google
Scholar]
453
Hui YH, Rupprecht JK, Liu YM, Anderson JE, Smith DL, Chang CJ,
133
462
Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, et al.
(2015) Annona muricata (Annonaceae): A review of its traditional uses, isolated
acetogenins and biological activities. Int J Mol Sci 16: 15625-15658. [Crossref]
463
Pieme CA, Kumar SG, Dongmo MS (2014) Antiproliferative activity and
induction of apoptosis by Annona muricata (Annonaceae) extract on human
cancer cells. BMC Complement Altern Med 14: 516. [Crossref]
464
Adewole, S. O. & Caxton-Martins, E. A. Morphological changes and
hypoglycemic effects of Annona muricata Linn. (Annonaceae) leaf aqueous
extract on pancreatic B-cells of streptozotocin-treated diabetic rats. Afr. J.
Biomed. Res. 9, 173–187 (2006).
136
Conclusion